Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy

Journal of Biological Chemistry

Volumn 288, Issue 17, 2013, Pages 11621-11627

  Zandarashvili, Levani ^a   Sahu, Debashish ^a   Lee, Kwanbok ^a   Lee, Yong Sun ^a   Singh, Pomila ^b   Rajarathnam, Krishna ^a   Iwahara, Junji ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE MEDIUMS; ENDOPLASMIC RETICULUM; EXTRACELLULAR ENVIRONMENTS; EXTRACELLULAR PROTEINS; HIGH-MOBILITY GROUPS; INFLAMMATORY DISEASE; PROSTATE CANCER CELLS; THERAPEUTIC TARGETS;

CELL CULTURE; CELL MEMBRANES; DISEASES; KINETICS; LIGANDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PROTEINS;

BODY FLUIDS;

DISULFIDE; GLYCYRRHIZIC ACID; HEPARAN SULFATE; HEPARIN; HIGH MOBILITY GROUP B1 PROTEIN; NITROGEN 15; THIOL;

ARTICLE; BLOOD CULTURE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR FLUID; FREEZE DRYING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIGAND BINDING; MALE; MULTICENTER STUDY; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION KINETICS; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; SALIVA ANALYSIS;

ADULT; AGED; CELL LINE, TUMOR; HALF-LIFE; HMGB1 PROTEIN; HUMANS; KINETICS; MALE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OXIDATION-REDUCTION; SALIVA;

EID: 84876943178     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.449942     Document Type: Article

References (46)

1. Ellgaard, L. (2004) Catalysis of disulphide bond formation inthe endoplasmic reticulum. Biochem. Soc. Trans. 32, 663-667
2. Ellgaard, L., and Helenius, A. (2003) Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4, 181-191
3. Chimini, G., and Rubartelli, A. (2005) Novel pathwaysofprotein secretion. in Molecular Chaperones and Cell Signaling (Henderson, B., and Pockley, A. G., eds) pp. 45-60, Cambridge University Press, Cambridge, United Kingdom
4. Muesch, A., Hartmann, E., Rohde, K., Rubartelli, A., Sitia, R., and Rapoport, T. A. (1990) A novel pathway for secretory proteins? Trends Biochem. Sci. 15, 86-88
5. Rubartelli, A., and Lotze, M. T. (2007) Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28, 429-436
6. Chaiswing, L., and Oberley, T. D. (2010) Extracellular/microenvironmental redox state. Antioxid. Redox Signal. 13, 449-465
7. Grek, C. L., and Tew, K. D. (2010) Redox metabolism and malignancy. Curr. Opin. Pharmacol. 10, 362-368
8. Blanco, R. A., Ziegler, T. R., Carlson, B. A., Cheng, P. Y., Park, Y., Cotsonis, G. A., Accardi, C. J., and Jones, D. P. (2007) Diurnal variation in glutathione and cysteine redox states in human plasma. Am. J. Clin. Nutr. 86, 1016-1023
9. Dröge, W. (2002) The plasma redox state and ageing. Ageing Res. Rev. 1, 257-278
10. 2 chemosensitivity. Blood 99, 1552-1555
11. Hildebrandt, W., Kinscherf, R., Hauer, K., Holm, E., and Dröge, W. (2002) Plasma cystine concentration and redox state in aging and physical exercise. Mech. AgeingDev. 123, 1269-1281
12. Schafer, F. Q., and Buettner, G. R. (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. FreeRadic. Biol. Med. 30, 1191-1212
13. Bianchi, M. E., and Manfredi, A. A. (2007) High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 220, 35-46
14. Lotze, M. T., and Tracey, K. J. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev. Immunol. 5, 331-342
15. Tang, D., Kang, R., Zeh, H. J., 3rd, and Lotze, M. T. (2011) High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 14, 1315-1335
16. Venereau, E., Schiraldi, M., Uguccioni, M., and Bianchi, M. E. (December 1, 2012) HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol. Immunol. 10.1016/j.molimm.2012.10.037
17. Orlova, V. V., Choi, E. Y., Xie, C., Chavakis, E., Bierhaus, A., Ihanus, E., Ballantyne, C. M., Gahmberg, C. G., Bianchi, M. E., Nawroth, P. P., and Chavakis, T. (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBOJ. 26, 1129-1139
18. Palumbo, R., Galvez, B. G., Pusterla, T., De Marchis, F., Cossu, G., Marcu, K. B., and Bianchi, M. E. (2007) Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation. J. Cell Biol. 179, 33-40
19. Riuzzi, F., Sorci, G., and Donato, R. (2006) The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J. Biol. Chem. 281, 8242-8253
20. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C, Hofmann, M. A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., Hori, O., Ogawa, S., Stern, D. M., and Schmidt, A. M. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354-360
21. Sahu, D., Debnath, P., Takayama, Y., and Iwahara, J. (2008) Redox properties of the A-domain of the HMGB1 protein. FEBSLett. 582, 3973-3978
22. Kazama, H., Ricci, J. E., Herndon, J. M., Hoppe, G., Green, D. R., and Ferguson, T. A. (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29, 21-32
23. Tang, D., Billiar, T. R., and Lotze, M. T. (2012) A Janus tale of two active HMGB1 redox states. Mol. Med. 18, 1360-1362
24. Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., Shams, S. S., Yang, H., Varani, L., Andersson, U., Tracey, K. J., Bachi, A., Uguccioni, M., and Bianchi, M. E. (2012) Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 209, 1519-1528
25. Liu, A., Fang, H., Dirsch, O., Jin, H., and Dahmen, U. (2012) Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion. PLoS ONE 7, e35379
26. Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., and Antoine, D. J. (2012) Redox modification of cysteine residues regulates the cytokine activity of HMGB1. Mol. Med. 18, 250-259
27. Kozlowski, J. M., Fidler, I. J., Campbell, D., Xu, Z. L., Kaighn, M. E., and Hart, I. R. (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res. 44, 3522-3529
28. Schanda, P., and Brutscher, B. (2005) Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds. J. Am. Chem. Soc. 127, 8014-8015
29. Schanda, P., Kupce, E., and Brutscher, B. (2005) SOFAST-HMQC experiments for recording two-dimensional heteronuclear correlation spectra of proteins within a few seconds. J. Biomol. NMR 33, 199-211
30. Pervushin, K., Riek, R., Wider, G., and Wüthrich, K. (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. U. S. A. 94, 12366-12371
31. Rance, M., Loria, J. P., and Palmer, A. G. (1999) Sensitivity improvement of transverse relaxation-optimized spectroscopy. J. Magn. Reson. 136, 92-101
32. Clore, G. M., and Gronenborn, A. M. (1998) Determining the structures of large proteins and protein complexes by NMR. Trends Biotechnol. 16, 22-34
33. Knapp, S., Müller, S., Digilio, G., Bonaldi, T., Bianchi, M. E., and Musco, G. (2004) The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes. Biochemistry 43, 11992-11997
34. Stott, K., Watson, M., Howe, F. S., Grossmann, J. G., and Thomas, J. O. (2010) Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tailto the A and B domains. J. Mol. Biol. 403, 706-722
35. Watson, M., Stott, K., and Thomas, J. O. (2007) Mapping intramolecular interactions between domains in HMGB1 using a tail-truncation approach. J. Mol. Biol. 374, 1286-1297
36. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe-a multidimensional spectral processing system based on Unix pipes. J. Biomol. NMR 6, 277-293
37. Johnson, B. A., and Blevins, R. A. (1994) NMRView-a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603-614
38. Ek, M., Popovic, K., Harris, H. E., Nauclér, C. S., and Wahren-Herlenius, M. (2006) Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome. Arthritis Rheum. 54, 2289-2294
39. Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., and Lotze, M. T. (2007) Masquerader: high mobility group box-1 and cancer. Clin. Cancer Res. 13, 2836-2848
40. Logsdon, C. D., Fuentes, M. K., Huang, E. H., and Arumugam, T. (2007) RAGE and RAGE ligands in cancer. Curr. Mol. Med. 7, 777-789
41. Lotze, M. T., and DeMarco, R. A. (2003) Dealing with death: HMGB1 as a novel target for cancer therapy. Curr. Opin. Investig. Drugs 4, 1405-1409
42. Tang, D., Kang, R., Zeh, H. J., 3rd, and Lotze, M. T. (2010) High-mobility group box 1 and cancer. Biochim. Biophys. Acta 1799, 131-140
43. Ulloa, L., and Messmer, D. (2006) High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 17, 189-201
44. Mollica, L., Curioni, A., Andreoni, W., Bianchi, M. E., and Musco, G. (2008) The binding domain of the HMGB1 inhibitor carbenoxolone: theory and experiment. Chem. Phys. Lett. 456, 236-242
45. Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., and Bianchi, M. E. (2007) Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem. Biol. 14, 431-441
46. Wake, H., Mori, S., Liu, K., Takahashi, H. K., and Nishibori, M. (2009) Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in Matrigel plug assay. Eur. J. Pharmacol. 623, 89-95